Chlorproguanil Hydrochloride/Dapsone

盐酸氯丙胍/氨苯砜

Report date: 2025/04/22 20:00:06

Base Information

Drug NameChlorproguanil Hydrochloride/Dapsone
Drug Alias NameChlorproguanil /Dapsone氯丙胍/氨苯砜盐酸氯丙胍+氨苯砜Chlorproguanil Hydrochloride- Dapsone mixt盐酸氯丙胍氨苯砜 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsMalaria, VivaxMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistanMaliMalawi +[4] 
CombinationsYes Chlorproguanil HydrochlorideDapsone
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcLiverpool School Of Tropical MedicineLondon School Of Hygiene And Tropical Medicine +[4] 
Active IndicationsN/A
Inactive IndicationsMalaria, VivaxMalaria

Other Information

ATC CodeN/A
Related LinksWikipedia